Shannon Quinn
Family · Salt Lake City, UTNPI 1215583059
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 445 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 50 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 445 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$584
- Lilly USA, LLC$558
- Viiv Healthcare Company$550
- Boehringer Ingelheim$453
- Gilead$373
- plus $4K from 44 others
What the payments were for
- Food & beverage$7,77399%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$7,858 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 45 | $47,100 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $18,210 |
| JardianceEmpagliflozin | 15 | $13,641 |
| EliquisApixaban | 11 | $10,024 |
| Arnuity ElliptaFluticasone Furoate | 11 | $2,901 |
| Omeprazole | 80 | $1,358 |
| Atorvastatin Calcium | 101 | $1,187 |
| Levothyroxine Sodium | 81 | $1,061 |
| Lisinopril | 79 | $1,007 |
| Amlodipine Besylate | 73 | $857 |
| Pravastatin Sodium | 34 | $797 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $754 |
| Hydroxyzine Hcl | 29 | $646 |
| Trazodone Hcl | 44 | $628 |
| Duloxetine Hcl | 25 | $627 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $558 | $47,10045 claims |
| AstraZenecaBreztri Aerosphere | $216 | $18,21018 claims |
| Boehringer IngelheimJardiance | $453 | $13,64115 claims |
| PfizerEliquis | $584 | $10,02411 claims |
| GSKArnuity Ellipta | $183 | $2,90111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,460 family providers in Utah.
Other family in Salt Lake City
- Katrina BawdenSalt Lake City$395K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Mary SteinbackSalt Lake City$189K
- Jennalyn MayeuxSalt Lake City$151K
- Kacie Doyle-DelgadoSalt Lake City$80K
- Melonie ThompsonSalt Lake City$45K
- Keisa LynchSalt Lake City$39K
- Christina CardonSalt Lake City$36K
- Jessica ArbogastSalt Lake City$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.